Walgreen Co. and The Kroger Co. are throwing their weight behind efforts to get a district court to halt Johnson & Johnson's exclusionary contracts that deter the purchase of biosimilars to J&J's Remicade (infliximab).
The two pharmacy chains filed suit against J&J and its subsidiary Janssen Biotech Inc. in the Eastern District of...